# John McIlwraith

> John McIlwraith is a Series B investor at Allos Ventures backing Software and Health Care. See 26 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Allos Ventures](https://shizune.co/investors/profile/allos-ventures)
- Location: Cincinnati, United States
- Total investments: 26
- Last investment: May 2024
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/john-mcilwraith-8663273

John McIlwraith is a Co-founder and Managing Director of Allos Ventures and Blue Chip Venture Company, Cincinnati venture capital firms that have invested in over 120 companies over the past 15 years. John has served on the board of directors of more than 25 of these companies including BlueGill Technologies, Blue Pillar, Inspiris, Juventas,Medhost, Nine Sigma, and Renal Solutions. He is an active member of the Midwest entrepreneurial community, including serving as a founding board member of the Michigan Venture Capital Association. Previously, John was senior vice president of strategic planning and general counsel of Quantum Health Resources, a public healthcare services company that provided drugs and related therapies to patients with rare, chronic diseases. Prior to Quantum, John was a partner with the Jones Day law firm where he co-founded the firm’s Private Ventures practice and represented venture capital firms and early-stage technology companies. John received a B.A. degree from Hillsdale College and a J.D. degree, magna cum laude, from Case Western Reserve University School of Law.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 4 | 15% |
| Health Care | 4 | 15% |
| Medical Device | 3 | 12% |
| Artificial Intelligence | 3 | 12% |
| Wireless | 2 | 8% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 6 | 23% |
| Series A | 5 | 19% |
| Seed | 2 | 8% |
| Series C | 2 | 8% |
| Series D | 2 | 8% |

9 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 10 | 38% |
| Japan | 1 | 4% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sift Healthcare | Sift Healthcare brings data science to healthcare payments, integrating machine learning and predictive analytics to reduce insurance denials, maximize patient payments and optimize revenue cycle operations. The company provides insights necessary to accelerate insurance payments, reduce overall denials, increase patient responsibility collections,monitor payer contracts and drive smarter workflows.Sift Healthcare captures insurance claim and patient financial data into a HIPAA-compliant, cloud-based and normalized database, providing a single source of truth for around your healthcare payments. By applying multiple data science techniques, Sift also provides comprehensive and integrated recommendations for denials management, payer assessment, patient collections and patient acquisition. | $20M | Series B | May 09, 2024 |  |
| Nichefire | Nichefire is an AI-power marketing analytics company. |  | Pre-Seed | Jul 01, 2023 |  |
| Raven360 | Raven360 empowers enterprises of all sizes to control intellectual property and other valuable content as it is shared externally. | $8M | Series B | Aug 04, 2022 |  |
| Carefeed | Carefeed's HIPAA secure SaaS platform digitizes any materials senior communities would like to share with their families. | $3M | Seed | Aug 02, 2022 |  |
| Sift Healthcare | Sift Healthcare brings data science to healthcare payments, integrating machine learning and predictive analytics to reduce insurance denials, maximize patient payments and optimize revenue cycle operations. The company provides insights necessary to accelerate insurance payments, reduce overall denials, increase patient responsibility collections,monitor payer contracts and drive smarter workflows.Sift Healthcare captures insurance claim and patient financial data into a HIPAA-compliant, cloud-based and normalized database, providing a single source of truth for around your healthcare payments. By applying multiple data science techniques, Sift also provides comprehensive and integrated recommendations for denials management, payer assessment, patient collections and patient acquisition. | $9M | Series A | Jul 15, 2022 |  |
| Rimsys | Rimsys is a world-leading Regulatory Information Management (RIM) software for medical technology companies. Built by and for regulatory affairs professionals, Rimsys digitizes, automates, and creates regulatory order to ensure products adhere to changing global regulations. It is the only holistic RIM software for medical devices, in-vitrodiagnostics, and medical device software that makes it easy to manage global UDI requirements and navigate the pillars of regulatory affairs, including product registration, standards management, essential principles/GSPR, and regulatory intelligence. | $16M | Series A | Dec 02, 2021 |  |
| 7SIGNAL | 7SIGNAL is an enterprise wireless experience monitoring. 7SIGNAL provides a cloud-based platform that continuously monitors wireless networks and identifies elusive performance issues impacting application performance. By taking the “outside-in” approach to monitoring 7SIGNAL has visibility into the edge of any enterprise or home Wi-Fi networkwhere complex device interaction exists, and user experience matters most. The platform maximizes employee productivity, operational efficiency, and network ROI. Designed for the world’s most innovative organizations, educational institutions, healthcare systems, and government agencies, the platform is currently deployed at Fortune 500 companies, hospitals, and large venues globally. | $5M | Series D | Jun 06, 2021 |  |
| Rimsys | Rimsys is a world-leading Regulatory Information Management (RIM) software for medical technology companies. Built by and for regulatory affairs professionals, Rimsys digitizes, automates, and creates regulatory order to ensure products adhere to changing global regulations. It is the only holistic RIM software for medical devices, in-vitrodiagnostics, and medical device software that makes it easy to manage global UDI requirements and navigate the pillars of regulatory affairs, including product registration, standards management, essential principles/GSPR, and regulatory intelligence. | $1.5M |  | Aug 18, 2020 |  |
| Rimsys | Rimsys is a world-leading Regulatory Information Management (RIM) software for medical technology companies. Built by and for regulatory affairs professionals, Rimsys digitizes, automates, and creates regulatory order to ensure products adhere to changing global regulations. It is the only holistic RIM software for medical devices, in-vitrodiagnostics, and medical device software that makes it easy to manage global UDI requirements and navigate the pillars of regulatory affairs, including product registration, standards management, essential principles/GSPR, and regulatory intelligence. | $1.5M | Seed | Aug 18, 2020 |  |
| Maven Machines | Maven Machines is a mobile cloud solution for trucking, transportation, and logistics industries. The company offers a modern fleet management solution that streamlines driver safety, real-time telematics, and alerting and automated compliance. It blends IoT sensors, artificial intelligence, software, and wireless communications to provide areal-time platform for both drivers and managers.Maven Machines was founded in 2014 and is headquartered in Pittsburgh, Pennsylvania. | $7M | Series A | Feb 05, 2020 |  |

10 of 26 investments shown.

## Co-investors
- [Claremont Creek Ventures](https://shizune.co/investors/profile/claremont-creek-ventures) — VC Fund, 6 deals together
- [Mutual Capital Partners](https://shizune.co/investors/profile/mutual-capital-partners-funds) — VC Fund, 5 deals together
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund, 4 deals together
- [Arsenal Growth Equity](https://shizune.co/investors/profile/arsenal-venture-partners) — VC Fund, 3 deals together
- [CincyTech](https://shizune.co/investors/profile/cincytech) — VC Fund, 3 deals together
- [EnerTech Capital](https://shizune.co/investors/profile/enertech-capital) — VC Fund, 3 deals together

## About Allos Ventures

VC Fund · Carmel, United States

Allos Ventures invests in early-stage B2B software and business services companies in the Midwest. The firm invests in businesses and partners with entrepreneurs to help these companies accelerate growth and build value. Allos Ventures was formed in early 2010 and is based in Carmel, Indiana, United States.

5 contacts available at Allos Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| David Kerr | Managing Director | https://shizune.co/investors/profile/david-kerr-2 |
| John McIlwraith | Co-founder & Managing Director | https://shizune.co/investors/profile/john-c-mcilwraith |
| Don Aquilano | Co-Founder & Managing Director | https://shizune.co/investors/profile/don-aquilano |
| Julie Whitehead | CFO | https://shizune.co/investors/profile/julie-whitehead |
| Victoria Bills | Associate | https://shizune.co/investors/profile/victoria-bills-3798 |

## Similar investors

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

## FAQ

### What does John McIlwraith invest in?

John McIlwraith invests primarily in Software, Health Care and Medical Device startups, most often at Series B and Series A stage. Most of the 26 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did John McIlwraith last invest?

The most recent investment recorded for John McIlwraith closed in May 2024. Shizune tracks 26 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co